2BB score and signals
Vanda Pharmaceuticals Inc.’s current 2BB score is 55 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 58 | Moderate |
| Momentum | 45 | Stable |
| Financial strength | 24 | Weak |
| Quality | 100 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| Headquarters | Washington, Washington, United States |
| Founded | 2002 |
| Employees | 533 |
| 52-week range | $4.27 – $9.94 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-09 | — | -0.4998 | — | $78.64M |
| 2026-10-27 | — | -0.6885 | — | $70.69M |
| 2026-08-05 | — | -0.5993 | — | $63.16M |
| 2026-05-06 | -0.82 | -0.7018 | $51.72M | $56.08M |
Related companies